Comparative analysis of minimum inhibitory concentration of various brands of cephalosporin against clinical isolates of staphylococcus aureus

Scientific Research and Essays

Volumn 6, Issue 31, 2011, Pages 6428-6434

  Farzana, K ^a   Noreen, S ^b   Nasir, B ^a   Azhar, S ^c   Mumtaz, A ^c   Sethi, A ^d   Asad, M H B ^c   Khan, B A ^e   Khan, S A ^c   Murtaza, G ^c  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b Nashtar Medical Hospital   (Pakistan)

^c COMSATS Institute of Information Technology ^*  (Pakistan)

^d GC UNIVERSITY   (Pakistan)

^e THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

Author keywords

Antibiotics; Cephalosporins; Local and multinational brands; Minimum inhibitory concentration; Staphylococcus aureus

Indexed keywords

EID: 84055221987     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: 10.5897/SRE11.008     Document Type: Article

References (23)

1. Acar J (1997). Consequences of bacterial resistance to antibiotics in medical practice. Clin. Infect. Dis., 24: S1-S17.
2. Ahmad A, Jameel N, Ansari FA, Khatoon H (2001). Multiple antibiotic resistance among Gram-negative bacteria isolated from milk in Karachi. Pak. J. Pharm. Sci., 14: 25-31
3. Ahmad M, Iqbal M, Akhtar N, Murtaza G, Madni MA (2010). Comparison of bioavailability and pharmacokinetics of diclofenac sodium and diclofenac potassium in healthy and Escherichia coliinduced febrile rabbits. Pak. J. Zool., 42: 395-400
4. Ahmad M, Raza H, Murtaza G, Akhtar N (2008). Pharmacokinetic variations of ofloxacin in normal and febrile rabbits. Pak. Vet. J., 28: 181-185
5. Andersen BM, Ringertz SH, Gullord TP, Hermansen W, Lelek M, Norman BI (2001). A three year survey of nosocomial and community-acquired infections, antibiotic treatment and re-hospitalizationin Norwegian health region. J. Hosp. Infect., 44: 214-223.
6. Bauer W, Kirby WMM, Sherris JC, Turk M (1996). Antibiotic susceptibility testing by a standardized single disc method. Am. J. Clin. Pathol., 45: 493-496
7. Collins CH, Lyne PM, Grange JM (1995). Identification methods. In; Collins CH, Lyne PM, Grange JM (eds). Microbiological method, 6th edn. Butter Worth. London, UK.
8. Connie RM, Geogre M (2000). Staphylococcus aureus. In; Connie RM, Geogre M (eds). Textbook of Diagnostic Microbiology. WB Saunder, UK
9. Edwards-Jones V, Childs C, Foster HA (1996). Cefotatan: Antibacterial activity against Staphylococcus aureus in the presence of human serum. Chemioter. Burns, 22: 384-389
10. Ejaz M, Murtaza G, Ahmad M, Khan SA, Saqib QNU, Asad MHHB, Waseem A, Farzana K, Hussain I (2011). Determination of the Prevalence of Entamoeba histolytica in Human at a Private Fertilizer Company Hospital in Pakistan using Microscopic Technique. Afr. J. Microbiol. Res., 5: 149-152
11. Espersen F (1995). Identifying the patient risk for Staphylococcus aureus blood stream infections. J. Chemother., 7: 11-17.
12. Farzana K, Hameed A, Waqas MK, Murtaza G, Saqib QNU, Waseem A, Asad MHHB, Hussain I (2011). Bactericidal activity of various brands of cephradine against Staphylococcus aureus. Int. J. Phys. Sci., 6: 1501-1507
13. Food and Drug Administration (2003). Food-borne pathogenic microorganisms and natural toxins handbook. http://vm.cfsan.fda.gov/~mow/chap3.html. Accessed at 18th August 2010.
14. Frobes BA, Sahm DF, Weissfeld AS (2002). Gastrointestinal tract infections. In; Frobes BA, Sahm DF, Weissfeld AS (eds). Bailey and Scott's Diagnostic Microbiology, 11th edn. Andrew-Allen, London, UK.
15. James PA, Reeves DS (1996). Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target. J. Chemother., 8: 37-47
16. Khalid A, Rehman UU, Sethi A, Khilji S, Fatima U, Khan MI, Waqas MK, Saqib QNU, Asad MHHB, Farzana K, Mahmood S, Waseem A, Ismail T, Murtaza G (2011). Antimicrobial activity analysis of extracts of Acacia modesta, Artimisia absinthium, Nigella sativa and Saussurea lappa against Gram positive and Gram negative microorganisms. Afr. J. Biotechnol., 10: 4574-4580
17. Khalid A, Waseem A, Saadullah M, Rehman UU, Khiljee S, Sethi A, Asad MHHB, Rasool F, Waqas MK, Murtaza G (2011). Antibacterial activity analysis of extracts of various plants against gram -positive and -negative bacteria. Afr. J. Pharm. Pharmacol., 5: 887-893.
18. Kunin CM (1993). Resistance to antimicrobial drugs a world wide calamity. Ann. Intern. Med., 118: 557-561
19. Lowy FD (1998). Staphylococcus aureus infection. New Eng. J. Med., 339: 520-532
20. Mahmood A, Rafique S, Qayyum M, Qazilbash AA (2001). Prevalence of nosocomial and community-based methicillin-resistant staphylococcus aureus (MRSA). Pak. J. Med. Res., 40: 86-89.
21. National Committee for Clinical Laboratory Standards (1993). 3rd edn. Document M7-A3, vol. 13, No, 25. National Committee for Clinical Laboratory Standards, 6: 915-921
22. Neiss HC (1973). Cepharadine; Summary of preclinical studies and clinical pharmacology. J. Irish Med. Assoc., 66: 1-12
23. Polk R (1999). Optimal use of modern antibiotics: Emerging trends. Clin. Infect. Dis., 29: 264-274.